Michael Chang

Michael Chang is a co-founder and CEO of Tether Therapeutics, where the focus is on developing next-generation mRNA therapeutics for respiratory diseases. In addition to this role, Michael serves as a venture partner at both Global Health Investment Corporation and Adjuvant Capital, concentrating on investments in the life sciences and global health sectors. Previously, Michael worked as an investment officer at the Bill & Melinda Gates Foundation, where responsibilities included managing the Global Health Division and Strategic Investment Fund. Early career experiences involved equity research in specialty pharmaceuticals at Piper Jaffray and M&A advisory at Stifel Financial Corp. Michael holds a Master of Public Health in Emerging Infectious Diseases from Johns Hopkins Bloomberg School of Public Health and a Bachelor of Arts in International Studies and Economics from The Johns Hopkins University.